SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Disclose 15% Stake in Nuvation Bio Inc. Class A Common Stock

FMR LLC and its affiliates, along with Abigail P. Johnson, have reported a combined beneficial ownership of 15.0% of Nuvation Bio Inc.'s Class A Common Stock as of March 31, 2025.

Summary

• FMR LLC and Abigail P. Johnson collectively beneficially own 50,599,225 shares of Nuvation Bio Inc.'s Class A Common Stock.
• This represents 15.0% of the total outstanding Class A Common Stock.
• FMR LLC holds sole voting power over 50,594,711 shares and sole dispositive power over 50,599,225 shares.
• Abigail P. Johnson, as an individual, holds sole dispositive power over 50,599,225 shares, but no sole or shared voting power.
• Fidelity Growth Company Commingled Pool holds 19,388,433 shares, representing 5.7% of the Class A Common Stock, and has the right to receive dividends or proceeds.
• The filing is an Amendment No. 7 to a Schedule 13G, indicating a passive investment position.

Sentiment

Score: 6

Explanation: The document is a routine beneficial ownership disclosure, indicating a significant and stable stake by a major institutional investor, which is generally viewed as a neutral to slightly positive signal of confidence.

Positives

• A major institutional investor, FMR LLC, and its affiliates, along with Abigail P. Johnson, maintain a significant 15.0% beneficial ownership stake in Nuvation Bio Inc., indicating continued confidence in the company.

Future Outlook

NA

Industry Context

This filing indicates a significant, passive investment by a major asset manager in Nuvation Bio Inc., a biotechnology company. Such Schedule 13G filings are routine for large institutional investors maintaining positions above 5% in publicly traded companies.

Comparison to Industry Standards

• This is a standard disclosure for a passive investor holding over 5% of a company's stock.
• The ownership percentage of 15.0% is substantial for a single entity/group, placing FMR LLC among the largest shareholders of Nuvation Bio Inc.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder's stake, potentially offering a signal of confidence in the company's long-term prospects.

Key Dates

Keywords

Nuvation Bio Inc, FMR LLC, Abigail P. Johnson, Schedule 13G, beneficial ownership, Class A Common Stock, institutional investor, SEC filing, equity stake